Butterfly Medical
Stub active Updated May 16, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
About
Butterfly Medical is a Yokneam, Israel-based medical device company founded in 2014 that is developing the Butterfly device — a first-line interventional therapy for benign prostatic hyperplasia (BPH), a non-surgical implant that retracts the prostate to relieve lower urinary tract symptoms 12. The $21M upsized Series C announced May 14, 2026 included participation from the European Innovation Council (EIC), Junson Capital, MedVenture, and New Rhein Healthcare Investors; proceeds will fund the FDA regulatory pathway and global commercialization 12.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-05-14 | Series C | $21M | — | European Innovation Council, Junson Capital, MedVenture, New Rhein Healthcare Investors 12 |
What Investors Say
No independently sourced investor quotes found at this time.
What Founders Say
No independently sourced founder quotes found at this time.
Sources
-
PR Newswire, “Butterfly Medical Secures $21 Million in Upsized Series C Funding to Advance Minimally Invasive BPH Treatment,” May 14, 2026. Accessed May 2026. https://www.prnewswire.com/news-releases/butterfly-medical-secures-21-million-in-upsized-series-c-funding-to-advance-minimally-invasive-bph-treatment-302772142.html↩↩↩
-
MassDevice, “Butterfly Medical raises $21M for BPH device,” May 14, 2026. Accessed May 2026. https://www.massdevice.com/butterfly-medical-raises-21m-bph-device/↩↩↩